Wk. Nicholson et al., Hormone replacement therapy for African American women: Missed opportunities for effective intervention, MENOPAUSE, 6(2), 1999, pp. 147-155
Citations number
105
Categorie Soggetti
Reproductive Medicine
Journal title
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Objectives: Because of the potential benefits and risks of hormone replacem
ent therapy (HRT), information about the efficacy of HRT in different group
s of women is important to patients and providers. The objectives of this s
tudy were to review the evidence on the benefits and risks of HRT in Africa
n American women and to present a quantitative analysis of the potential re
duction in mortality from osteoporotic fractures and coronary heart disease
and the potential increase in risk of breast and endometrial cancer.
Methods: A MEDLINE search of English-language observational studies and cli
nical trials on the effects of HRT on osteoporotic fractures and coronary h
eart disease (CHD) was conducted for the time period from 1966 to September
1998. Using available CHD mortality data for African American women and wh
ite women, potential reductions in mortality with HRT were explored for Afr
ican American and white women.
Results: In the 30 studies on CHD and HRT, African American women were know
n to comprise only 173 (0.1%) of 148,437 participants. In 11 studies of HRT
and osteoporotic fractures, only 128 (0.4%) of 40,299 participants were kn
own to be African American women. An analysis of CHD mortality by decade in
tervals indicated that African American women, aged 55 to 64, are more like
ly to die from CHD each year than white women. Despite a lower incidence of
breast and endometrial cancer among African American women, the mortality
rates of African American women with these cancers is higher compared with
white women.
Conclusions: With the higher underlying CHD mortality rate among African Am
erican women, HRT is an important potential preventive therapy. The absence
of African American women and other non-white women from clinical studies
of HRT makes it difficult to fully assess the risks and benefits of HRT in
this group of women. (Menopause 1999,6: 147-155. (C) 1999, The North Americ
an Menopause Society.)